Other or unspecified paralytic strabismus

H7_PARASTRANAS

paralytic strabismus: An ocular deviation caused by a palsy to one or more of the extraocular muscles or nerves supplying them. [database_cross_reference: ORCID:0000-0003-0986-4123][database_cross_reference: ORCID:0000-0003-0986-4123]

Suggest a new description

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 H49.8, H49.9
  • Hospital discharge: ICD-9 3785
  • Hospital discharge: ICD-8 37304
  • Cause of death: ICD-10 H49.8, H49.9
  • Cause of death: ICD-9 3785
  • Cause of death: ICD-8 37304

2 out of 7 registries used, show all original rules.

257

4. Check minimum number of events

None

257

5. Include endpoints

None

257

6. Filter based on genotype QC (FinnGen only)

257

Control definitions (FinnGen only)

Control exclude
H7_OCUMUSCLE

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2784 1425 1332
Only index persons 1919 1005 914
Unadjusted period prevalence (%)
Whole population 0.04 0.04 0.04
Only index persons 0.04 0.04 0.03
Median age at first event (years)
Whole population 47.92 50.73 44.72
Only index persons 40.99 43.75 37.95

-FinnGen-

Key figures

All Female Male
Number of individuals 257 132 125
Unadjusted period prevalence (%) 0.05 0.04 0.06
Median age at first event (years) 44.56 42.47 46.78

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
229
Matched controls
2291
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
3785A
ICD-9 Finland
Strabismus and other disorders of binocular eye movements, Paralytic strabismus
+∞
98.2
87
*
37304
ICD-8 Finland
Strabismus, paralyticus. Paresis nervorum III, IV, VI
+∞
81.2
73
*
H49.9
ICD-10 Finland
Paralytic strabismus, unspecified
+∞
46.5
43
*
H49.8
ICD-10 Finland
Other paralytic strabismus
+∞
34.2
32
*
H53.2
ICD-10 Finland
Diplopia
26.3
24.8
34
15
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
+∞
23.3
22
*
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
+∞
21.2
20
*
3503
FHL
Single muscle retroposition
+∞
15.8
15
*
H50.2
ICD-10 Finland
Vertical strabismus
+∞
11.6
11
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
4.7
11.0
38
92
37300
ICD-8 Finland
Strabismus, Concomitans convergens
+∞
10.5
10
*
CEC10
NOMESCO Finland
Recession and resection of extraocular muscle
+∞
9.4
9
*
3505
FHL
Single muscle resection
+∞
9.4
9
*
H49.1
ICD-10 Finland
Fourth [trochlear] nerve palsy
+∞
9.4
9
*
CEC00
NOMESCO Finland
Recession of extraocular muscle
+∞
9.4
9
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.9
6.9
44
176
N07AA02
ATC
pyridostigmine; systemic
71.8
6.5
7
*
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
4.3
6.3
22
55
H49.4
ICD-10 Finland
Progressive external ophthalmoplegia
+∞
6.3
6
*
CEC60
NOMESCO Finland
Transposition of extraocular muscle with adjustable suture
+∞
6.3
6
*
3507
FHL
Retroposition and resection
+∞
6.3
6
*
CEW99
NOMESCO Finland
Other operation on extraocular muscle
+∞
6.3
6
*
H02.4
ICD-10 Finland
Ptosis of eyelid
6.3
6.1
15
25

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
20
36
5.94
10.88
2.1
1.5
—
—
—
0
0
45
220
2.27
5.33
2.9
1.6
—
—
—
0
0
123
936
1.60
3.41
6.1
6.4
1.2
1.2
mmol/l
0.13
107
786
8
15
5.47
3.21
2.4
1.1
—
—
—
0
0
7
12
5.96
3.04
1.4
1.3
—
—
—
0
0
28
146
2.03
2.83
2.9
2.5
—
15.9
—
0
6
11
37
3.06
2.72
1.5
1.6
1.3
6.7
iu/l
—
5
9
15
61
2.55
2.67
6.3
4.5
—
—
—
0
0
167
1410
1.53
2.64
4.1
3.8
15.2
14.8
pmol/l
1.32
157
1270
100
760
1.52
2.61
9.4
9.0
1.2
1.3
inr
0.46
29
205
110
861
1.49
2.46
6.1
5.4
1.2
1.2
mmol/l
0.22
100
776
75
542
1.54
2.45
3.4
3.9
—
—
—
0
0
52
346
1.63
2.40
1.7
1.7
1172.5
1207.1
nmol/l
0.10
39
268
31
179
1.83
2.35
2.8
3.1
—
—
—
0
0
67
478
1.54
2.31
4.9
3.6
88.7
91.0
%
0.34
67
468
5
9
5.64
2.22
1.0
1.0
—
—
—
0
0
5
10
5.07
2.08
1.0
1.1
—
—
—
0
0
7
20
3.57
2.07
2.4
1.5
—
—
—
0
0
20
107
1.94
1.92
10.6
9.1
93.9
93.9
%
0.01
20
107
53
375
1.52
1.88
2.9
2.7
575.4
567.7
mosm/kgh2o
0.08
48
319
104
838
1.40
1.88
6.5
6.0
0.7
0.7
%
0.03
94
779
77
588
1.44
1.88
3.4
2.9
—
—
—
0
0
19
102
1.93
1.81
5.3
3.6
—
—
—
0
0
23
133
1.80
1.77
7.4
5.8
8.0
9.6
mmol/l
0.53
23
125
12
54
2.28
1.77
1.0
2.7
40.7
39.3
g/l
0.66
12
46
105
855
1.39
1.76
6.7
6.0
3.0
2.7
%
0.58
94
794
106
866
1.38
1.74
6.7
5.9
58.7
57.7
%
0.34
97
817
14
68
2.12
1.73
5.8
5.8
0.8
0.9
%
0.43
14
59
105
859
1.38
1.70
7.1
6.3
8.7
8.7
%
0.03
95
806
131
1111
1.37
1.69
6.2
4.5
6.5
6.8
mmol/l
0.83
123
1040
14
69
2.09
1.68
5.8
5.8
1.7
1.5
%
0.33
14
59
115
957
1.36
1.67
6.3
6.1
0.2
0.2
e9/l
1.27
102
840
111
921
1.36
1.63
6.1
5.9
0.6
0.6
e9/l
0.02
91
803
111
925
1.35
1.57
6.1
5.9
0.0
0.0
e9/l
0.53
93
806
11
213
0.49
1.50
1.4
1.2
—
—
—
0
0
77
613
1.37
1.44
2.1
2.2
—
—
—
0
0
5
16
3.17
1.44
1.0
1.6
—
—
—
0
0
6
22
2.77
1.44
1.0
1.1
—
—
—
0
0
6
22
2.77
1.44
1.0
1.1
—
—
—
0
0
105
877
1.33
1.44
6.9
6.1
26.7
27.3
%
0.20
95
820
32
218
1.53
1.36
4.9
4.6
1.0
1.0
mmol/l
0.53
32
197
111
941
1.32
1.35
6.5
5.8
2.1
1.8
e9/l
0.39
96
831
46
340
1.43
1.32
3.5
3.6
187.4
272.6
ng/l
0.18
39
264
76
615
1.33
1.27
6.4
5.6
—
—
—
0
0
8
36
2.26
1.25
4.1
3.6
33.9
37.1
umol/l
—
8
31
14
78
1.84
1.23
7.8
9.4
—
—
—
0
0
23
149
1.60
1.22
7.3
7.0
—
—
—
0
0
5
19
2.66
1.22
1.0
1.7
14.3
13.8
ug/l
—
5
19
71
575
1.32
1.18
3.7
3.7
7.4
7.4
ph
0.87
11
109
66
530
1.33
1.16
3.0
2.9
0.3
0.5
e6/l
0.54
54
382
0
36
0.00
1.15
0.0
1.4
—
—
—
0
0
7
30
2.37
1.13
2.4
2.8
101.4
106.3
mmol/l
—
7
30
7
30
2.37
1.13
2.4
2.8
4.1
4.0
mmol/l
—
7
30
7
30
2.37
1.13
2.4
2.8
—
—
—
0
0
64
516
1.32
1.09
3.1
2.8
—
—
—
0
0
123
1084
1.26
1.04
9.1
9.9
5.1
4.1
e9/l
0.87
103
950
5
22
2.30
1.04
1.2
1.3
—
—
—
0
0
20
131
1.57
1.03
1.2
2.5
—
—
—
0
0
5
23
2.20
0.98
1.8
1.3
—
—
—
0
0
31
226
1.42
0.98
1.8
1.4
—
—
—
0
0
53
423
1.32
0.97
2.0
1.8
0.9
1.2
mg/l
0.44
38
329
6
27
2.25
0.94
3.5
1.7
—
—
—
0
0
9
52
1.76
0.93
1.0
1.2
—
—
—
0
0
55
668
0.78
0.90
3.7
2.9
—
—
—
0
0
58
474
1.29
0.90
6.3
6.8
—
—
—
0
0
81
690
1.25
0.90
3.7
3.5
772.9
80.1
e6/l
0.68
61
475
13
79
1.68
0.90
2.5
2.8
25.3
23.9
mmol/l
1.12
13
73
12
72
1.70
0.86
1.2
2.0
0.8
1.8
ug/l
0.63
12
64
15
96
1.60
0.86
2.5
2.9
—
—
—
0
0
88
761
1.24
0.85
2.1
1.9
99.9
95.1
pmol/l
0.42
50
387
12
73
1.68
0.83
10.0
4.2
—
—
—
0
0
14
89
1.61
0.83
2.6
2.5
—
—
—
0
0
184
1721
1.24
0.82
5.5
4.6
2.0
1.9
mu/l
0.24
174
1557
95
832
1.22
0.81
10.2
9.5
0.0
0.0
e9/l
0.24
71
673
74
631
1.24
0.81
3.3
3.3
2.4
2.4
mmol/l
0.44
62
548
23
165
1.43
0.81
11.0
7.8
114.9
121.7
g/l
0.66
23
156
25
183
1.41
0.79
10.2
7.5
95.8
95.4
%
0.18
25
171
69
587
1.24
0.77
3.3
3.0
135.9
46.5
e6/l
0.54
59
442
160
1481
1.21
0.77
9.0
7.6
83.5
79.0
u/l
0.54
148
1372
9
54
1.69
0.75
1.9
3.4
—
—
—
0
0
143
1312
1.20
0.74
5.0
4.3
—
—
—
0
0
11
169
0.64
0.72
1.1
1.4
—
—
—
0
0
5
26
1.94
0.71
3.6
2.5
—
—
—
0
0
49
405
1.26
0.70
1.7
1.7
443.5
441.2
pmol/l
0.03
40
340
34
270
1.30
0.67
2.4
1.9
2.3
2.4
g/l
0.13
29
247
5
28
1.80
0.66
1.2
1.1
—
—
—
0
0
18
129
1.43
0.65
2.4
2.5
—
—
—
0
0
8
51
1.59
0.61
1.8
1.2
—
—
—
0
0
26
204
1.31
0.57
10.0
7.1
12.2
12.0
kpa
0.11
26
192
26
204
1.31
0.57
10.0
7.1
5.0
5.1
kpa
0.14
26
191
15
107
1.43
0.56
1.3
1.2
309.3
155.7
iu/ml
—
5
43
53
454
1.21
0.56
2.0
1.9
3.7
3.4
mg/l
0.26
47
387
19
142
1.37
0.56
2.6
3.0
65.2
72.0
e9/l
0.77
11
110
10
147
0.67
0.55
1.5
1.5
—
—
—
0
0
13
92
1.44
0.51
9.5
9.4
25.5
24.3
mmol/l
0.71
13
85
15
199
0.74
0.48
1.2
1.3
—
—
—
0
0
7
49
1.44
0.46
1.1
1.1
—
—
—
0
0
5
85
0.58
0.46
1.4
1.6
—
—
—
0
0
65
579
1.16
0.45
3.2
2.9
8.2
7.8
mmol/l
0.23
53
480
30
248
1.24
0.45
1.4
1.3
320.0
536.6
titre
—
5
58
16
121
1.34
0.45
9.4
4.3
—
—
—
0
0
5
31
1.62
0.43
2.2
3.5
55.6
57.9
%
—
5
31
8
56
1.44
0.43
1.5
1.3
—
—
—
0
0
8
59
1.37
0.41
2.8
2.6
1.6
1.4
mg/l
—
8
53
0
16
0.00
0.41
0.0
1.7
—
—
—
0
0
0
16
0.00
0.41
0.0
5.7
—
—
—
0
0
8
60
1.34
0.40
1.5
1.6
—
—
—
0
0
5
34
1.48
0.40
12.0
6.6
10.8
12.1
mmol/l
—
5
26
5
34
1.48
0.40
12.0
6.6
108.8
103.6
mmol/l
—
5
26
7
105
0.66
0.40
1.6
1.4
—
—
—
0
0
39
337
1.19
0.39
4.1
2.9
2.4
2.5
mmol/l
0.28
32
299
64
577
1.15
0.38
4.2
3.8
10.5
9.3
mg/mmol
0.07
40
363
5
36
1.40
0.38
1.8
1.3
316.0
263.3
u/ml
—
5
22
9
68
1.34
0.38
2.1
2.5
—
—
—
0
0
22
180
1.24
0.37
1.2
1.4
—
—
—
0
0
11
81
1.37
0.37
1.2
1.3
—
—
—
0
0
26
218
1.21
0.36
1.3
1.3
—
—
—
0
0
6
42
1.44
0.36
2.3
1.4
—
—
—
0
0
6
42
1.44
0.36
1.2
1.5
—
—
—
0
0
83
767
1.12
0.34
4.1
3.9
35.6
33.5
ng/l
0.09
66
538
60
544
1.13
0.33
3.4
3.1
50.2
170.5
mg/l
0.49
38
351
16
130
1.25
0.29
1.1
1.5
—
—
—
0
0
50
453
1.13
0.29
1.5
1.6
20.9
21.8
nmol/l
0.19
42
378
36
319
1.15
0.28
1.3
1.3
20.4
33.6
iu/ml
0.57
14
94
8
65
1.24
0.27
8.0
11.3
—
—
—
0
0
13
104
1.26
0.27
1.3
1.2
—
—
—
0
0
81
758
1.10
0.26
2.5
2.1
—
—
—
0
0
19
160
1.20
0.26
1.2
1.4
—
—
—
0
0
9
72
1.26
0.26
1.7
1.6
—
—
—
0
0
12
96
1.26
0.25
10.4
5.7
25.8
24.5
mmol/l
0.59
12
96
53
488
1.11
0.24
1.3
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
7.5
—
0.7
—
0
11
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
4.2
—
—
—
0
0
0
10
0.00
0.21
0.0
8.3
—
—
—
0
0
0
12
0.00
0.21
0.0
2.5
—
8.5
—
0
12
146
1413
1.08
0.21
4.1
4.0
13.8
11.9
mm/h
0.87
140
1298
0
13
0.00
0.21
0.0
3.7
—
37.9
—
0
8
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
3.3
—
21.7
—
0
9
0
14
0.00
0.20
0.0
3.1
—
—
—
0
0
185
1809
1.08
0.19
4.1
4.0
1.3
1.3
mmol/l
0.07
171
1658
12
142
0.84
0.18
1.2
1.2
—
—
—
0
0
5
66
0.75
0.17
1.0
1.4
—
—
—
0
0
5
67
0.74
0.17
1.0
1.4
—
—
—
0
0
5
67
0.74
0.17
1.0
1.3
—
—
—
0
0
5
67
0.74
0.17
1.0
1.4
—
—
—
0
0
206
2027
1.08
0.16
20.3
16.5
76.6
76.9
umol/l
0.05
206
2027
19
214
0.88
0.16
2.5
1.9
260.9
127.5
ug/g
0.37
14
170
6
77
0.77
0.16
3.8
3.2
19.2
2028.2
u/ml
—
6
64
32
294
1.10
0.15
2.7
1.8
—
—
—
0
0
11
128
0.85
0.14
3.2
2.6
282.8
173.9
ng/l
0.22
11
114
9
108
0.83
0.13
1.0
1.3
—
—
—
0
0
42
395
1.08
0.13
1.2
1.2
0.7
1.7
u/ml
1.01
15
106
42
442
0.94
0.10
4.3
3.6
—
—
—
0
0
100
975
1.04
0.09
4.7
3.7
0.0
0.0
estimate
0.00
17
164
5
62
0.80
0.08
1.0
1.4
—
—
—
0
0
23
246
0.93
0.08
1.7
1.5
—
—
—
0
0
56
540
1.05
0.08
4.6
3.3
—
—
—
0
0
7
65
1.08
0.08
9.3
3.5
3.8
3.9
mmol/l
—
7
57
194
1920
1.04
0.07
5.3
4.8
2.7
2.7
mmol/l
0.59
181
1764
169
1711
0.96
0.07
20.0
14.9
38.1
39.9
%
1.23
120
1239
97
951
1.03
0.06
4.5
3.7
0.0
0.0
estimate
0.00
17
173
179
1772
1.03
0.06
6.7
5.7
39.9
40.2
mmol/mol
0.20
168
1645
31
296
1.05
0.06
1.7
1.8
—
—
—
0
0
40
415
0.96
0.06
6.4
5.3
—
—
—
0
0
57
584
0.97
0.04
4.1
4.0
—
—
—
0
0
210
2113
0.97
0.04
25.8
20.7
4.5
4.5
e12/l
0.34
203
2045
210
2113
0.97
0.04
25.9
20.8
7.5
6.7
e9/l
1.05
202
2044
49
503
0.97
0.04
4.5
3.9
0.0
0.0
estimate
0.00
16
165
39
378
1.04
0.04
3.2
2.9
0.6
0.7
ug/l
1.07
25
240
134
1326
1.02
0.04
3.9
3.9
—
—
—
0
0
25
260
0.96
0.03
1.0
1.2
—
—
—
0
0
210
2111
0.97
0.03
25.8
20.8
254.8
248.7
e9/l
0.75
203
2052
18
189
0.95
0.03
1.7
1.5
—
—
—
0
0
95
960
0.98
0.02
6.9
5.0
0.0
0.0
estimate
0.00
17
173
65
641
1.02
0.02
4.5
4.8
2.1
2.5
ug/l
0.34
56
571
189
1881
1.02
0.02
4.6
4.4
4.6
4.7
mmol/l
0.63
176
1737
185
1858
0.98
0.01
4.8
4.5
6.0
6.0
mmol/l
0.07
170
1694
21
203
1.04
0.01
1.6
1.5
—
—
—
0
0
191
1917
0.99
0.01
18.9
14.2
24.8
24.1
mg/l
0.11
161
1505
15
156
0.96
0.00
3.0
3.9
—
—
—
0
0
19
184
1.04
0.00
4.2
4.3
—
—
—
0
0
15
151
0.99
0.00
4.9
3.2
—
—
—
0
0
42
417
1.01
0.00
4.6
4.1
1.0
1.0
kg/l
—
9
54
199
1993
0.99
0.00
17.5
13.1
—
—
—
0
0
203
2027
1.01
0.00
12.6
10.4
28.9
26.6
u/l
0.83
196
1955
32
315
1.02
0.00
1.3
1.2
4.5
10.2
u/ml
0.66
13
113
36
364
0.99
0.00
1.4
1.5
2.4
2.6
g/l
0.40
24
227
14
135
1.04
0.00
1.9
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
16.4
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
5
55
0.91
0.00
1.2
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
5
58
0.86
0.00
1.2
4.6
27.9
28.8
mg/l
—
5
44
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
8
85
0.94
0.00
1.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
5
54
0.92
0.00
1.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
2.0
—
17.7
—
0
6
187
1870
1.00
0.00
4.6
4.4
1.4
1.5
mmol/l
0.28
174
1720
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
5
58
0.86
0.00
1.2
4.6
45.5
66.2
mg/l
—
5
44
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint H7_PARASTRANAS and mortality.

Females

Parameter HR [95% CI] p-value
H7_PARASTRANAS 1.516 [1.09, 2.11] 0.013
Birth year 0.989 [0.98, 1.0] 0.017

During the follow-up period (1.1.1998 — 31.12.2019), 71 out of 277 females with H7_PARASTRANAS died.

Males

Parameter HR [95% CI] p-value
H7_PARASTRANAS 1.878 [1.32, 2.67] < 0.001
Birth year 0.986 [0.98, 1.0] 0.005

During the follow-up period (1.1.1998 — 31.12.2019), 75 out of 298 males with H7_PARASTRANAS died.

Mortality risk

Mortality risk for people of age

years, who have H7_PARASTRANAS.

N-year risk Females Males
1 0.103% 0.306%
5 0.822% 1.925%
10 1.879% 5.128%
15 3.335% 9.938%
20 6.096% 16.04%

Relationships between endpoints

Index endpoint: H7_PARASTRANAS – Other or unspecified paralytic strabismus

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data